The Precision Peptide Genetic Test (available as a $99 add-on after your first month of semaglutide or other GLP-1 treatment) provides these personalized insights, enabling a truly customized nutrition strategy alongside your medication regimen
The medication that is deemed the best fit will vary from patient to patient and will be decided upon by the patient and their weight loss specialist to choose the option that will yield the most effective, safest, and sustainable results
but was recently withdrawn as data indicated that it increased cancer risk
This testing informs whether semaglutide alone, or combination therapy with tirzepatide, aligns better with your genetic predispositions for weight loss and metabolic controlensuring proper medication selection and dosing strategy from the start
and licensed by Eli Lilly in 2018
If you are aware of fraud being committed against federal or state governments, your reporting is confidential and protected by the FCA